Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms
Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …
[HTML][HTML] A review of 3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy
B Sessa, L Higbed, D Nutt - Frontiers in psychiatry, 2019 - frontiersin.org
This paper provides a brief review of the history, proposed pharmacological mechanisms,
safety issues, and clinical applications of the medicine 3, 4 …
safety issues, and clinical applications of the medicine 3, 4 …
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Lysergic acid diethylamide (LSD) is a classic psychedelic, 3, 4-
methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a …
methylenedioxymethamphetamine (MDMA) is an empathogen, and d-amphetamine is a …
Acute effects of lysergic acid diethylamide in healthy subjects
Y Schmid, F Enzler, P Gasser, E Grouzmann… - Biological …, 2015 - Elsevier
Background After no research in humans for> 40 years, there is renewed interest in using
lysergic acid diethylamide (LSD) in clinical psychiatric research and practice. There are no …
lysergic acid diethylamide (LSD) in clinical psychiatric research and practice. There are no …
A randomized, controlled pilot study of MDMA (±3, 4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic …
P Oehen, R Traber, V Widmer… - Journal of …, 2013 - journals.sagepub.com
Psychiatrists and psychotherapists in the US (1970s to 1985) and Switzerland (1988–1993)
used MDMA legally as a prescription drug, to enhance the effectiveness of psychotherapy …
used MDMA legally as a prescription drug, to enhance the effectiveness of psychotherapy …
MDMA enhances emotional empathy and prosocial behavior
CM Hysek, Y Schmid, LD Simmler… - Social cognitive and …, 2014 - academic.oup.com
Methylenedioxymethamphetamine (MDMA,'ecstasy') releases serotonin and
norepinephrine. MDMA is reported to produce empathogenic and prosocial feelings. It is …
norepinephrine. MDMA is reported to produce empathogenic and prosocial feelings. It is …
Toxicity of amphetamines: an update
Amphetamines represent a class of psychotropic compounds, widely abused for their
stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and …
stimulant, euphoric, anorectic, and, in some cases, emphathogenic, entactogenic, and …
Alterations of consciousness and mystical-type experiences after acute LSD in humans
ME Liechti, PC Dolder, Y Schmid - Psychopharmacology, 2017 - Springer
Rationale Lysergic acid diethylamide (LSD) is used recreationally and in clinical research.
Acute mystical-type experiences that are acutely induced by hallucinogens are thought to …
Acute mystical-type experiences that are acutely induced by hallucinogens are thought to …
Acute subjective effects in LSD-and MDMA-assisted psychotherapy
Y Schmid, P Gasser, P Oehen… - Journal of …, 2021 - journals.sagepub.com
Background: Lysergic acid diethylamide (LSD) and 3, 4-methylenedioxymethamphetamine
(MDMA) were used in psychotherapy in the 1960s–1980s, and are currently being re …
(MDMA) were used in psychotherapy in the 1960s–1980s, and are currently being re …
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review
A Sarparast, K Thomas, B Malcolm, CS Stauffer - Psychopharmacology, 2022 - Springer
Abstract Rationale & objectives±3, 4-Methylenedioxymethamphetamine (MDMA) and
psilocybin are currently moving through the US Food and Drug Administration's phased drug …
psilocybin are currently moving through the US Food and Drug Administration's phased drug …